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Abstract
DNAzymes have been widely explored owing to their excellent catalytic activity in 
a broad range of applications, notably in sensing and biomedical devices. These 
newly discovered applications have built high hopes for designing novel catalytic 
DNAzymes. However, the selection of efficient DNAzymes is a challenging process 
but one that is of crucial importance. Initially, systemic evolution of ligands by ex-
ponential enrichment (SELEX) was a labor-intensive and time-consuming process, 
but recent advances have accelerated the automated generation of DNAzyme mol-
ecules. This review summarizes recent advances in SELEX that improve the affinity 
and specificity of DNAzymes. The thriving generation of new DNAzymes is expected 
to open the door to several healthcare applications. Therefore, a significant portion 
of this review is dedicated to various biological applications of DNAzymes, such as 
sensing, therapeutics, and nanodevices. In addition, discussion is further extended 
to the barriers encountered for the real-life application of these DNAzymes to pro-
vide a foundation for future research. 
Glossary 
Chromatography: a technique used for the physical separation of mixtures into 
their components. All forms of chromatography work on the same principle, 
in that, all have a stationary phase and a mobile phase. The approach is well-
known for its high sensitivity because of competitive interaction between the 
desired molecule and target immobilized stationary phase that are mainly com-
posed of agarose beads. 
Combinatorial chemistry: synthetic method used to prepare a library of structur-
ally related analogues in a single process. Currently, vast ranges of simulation 
software are used for generating combinatorial library. 
Electrochemical detection: the basic principle of electrochemical biosensors in-
volves immobilization of selected functional DNA molecules on an electrode 
surface that specifically bind to a ligand, which can further lead to a change in 
the current or voltage. 
Electrophoresis: analysis technique used to efficiently separate charged particles 
from each another based on differences in their mobility. It can be used to sep-
arate a variety of small and large target molecules. The major shortcoming as-
sociated is that the target molecule should have a sufficient size to induce mo-
bility changes. 
G-quadruplex DNAzyme: single-stranded G-rich aptamer sequences spontane-
ously form an intramolecular four-stranded helical structure (G4). Associates with 
the hemin group to form the catalytic G4-hemin-DNAzyme complex. This com-
plex DNAzyme catalyzes the oxidation reaction of hydrogen peroxide to result 
in the generation of chemiluminescence. 
Logic gate: a logic gate performs a logical operation (Boolean algebra) on given in-
puts in order to generate a single electrical output. Different logic gates are com-
bined using combinatorial or sequential approaches for computer programming. 
Basic logic gate series include-AND, OR, NOT, XOR, NOR, NAND, and XNOR.
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Metallozymes: enzymes that require metal ions as cofactors for their catalytic ac-
tivity. Although the metal cannot be bound in a permanent way to the enzyme, 
it is bound firmly to a specific region of the native conformation of the protein.
Michaelis–Menten kinetics: it is a fundamental equation for enzyme kinetics that 
relates rate of reactions [V], to substrate concentration [S] i.e., V = Kcat [Enzyme] 
[S]/(Km + [S]). PCR: polymerase chain reaction is a molecular technique used to 
exponentially amplify segments of a particular DNA sequence into millions or 
billions of copies. The strategy involves incorporation of a PCR primer and DNA 
polymerase with a template strand. The method has a major limitation in that it 
may give false positive results.
RNA interference (RNAi): RNA molecule based regulatory system. Directs enzyme 
complexes to degrade mRNA molecules. Different categories of these molecules 
include miRNA, small interfering RNA (siRNA), and small hairpin RNA (shRNA). 
Secondary conformations: 2D or 3D structures attained by single-stranded nu-
cleic acid through the use of hydrogen bonds. Stem loops, hairpins, tetraloops, 
and pseudo-knots are the most well-known conformations in the context of cat-
alytic molecules. 
SELEX: SELEX also known as ‘selected and amplified binding site’ (SAAB) and ‘cyclic 
amplification and selection of targets’ (CASTing) is an ‘in vitro selection’ method 
used for the isolation of DNA based catalytic molecules. It is an iterative method 
that includes selection, separation, and amplification of desired molecules. 
Theranostics: is an emerging field that deals with both imaging and therapeutics in 
one step. Initially, it was used only for nanomaterials as they are widely explored 
as both imaging agents and pharmaceutical agents, but now this has been ex-
panded to other novel materials. 
XNAzymes: oligonucleotide probes with altered sugar backbones have been dis-
covered and named xenonucleic acids (XNAs). These XNA molecules were syn-
thesized directly from DNA templates but replicated by means of specially en-
gineered mutant polymerases. These polymerases introduced errors, thereby 
producing novel XNA sequences catalyzing reactions termed as XNAzymes. 
DNAzymes – Catalytically Active DNA Molecules 
DNAzymes are functionally active, synthetic single-stranded (ss) DNA 
molecules that are capable of catalyzing biological reactions similarly 
to RNAzymes and proteins. DNA molecules as enzymatic molecules 
are synthesized using the in vitro selection method known as systemic 
evolution of ligands by exponential enrichment (SELEX; see Glossary). 
Selected DNAzymes consist of a central catalytic domain flanked by 
two sequences specifically designed to bind to the desired target se-
quence. These molecules, upon binding to the complementary se-
quence, can catalyze the cleavage of the target sequence using the 
Kumar  et  al .  in  Trends  in  B iochemical  Sc i ences  44  (2019 )      4
catalytic domain. DNAzyme-based molecular catalysts generally de-
pend on a metal ion cofactor for catalysis. It has also been reported 
that DNAzyme-mediated catalysis follows Michaelis– Menten kinet-
ics and can enhance the rate of reaction up to many folds [1]. Unlike 
proteins and RNAzymes, there are no reports of naturally occurring 
DNAzymes. 
The invention of self-splicing RNA catalysts raised the possibility 
that DNA molecules might also be used as catalysts. Catalytic DNA 
molecules are not as efficient as protein molecules because of the in-
ert nature of the monomeric units and the lower diversity of functional 
groups. Nonetheless, they are reported to have the advantage that 
they can form diverse structures and their easy manipulation has pro-
moted their use as potent catalytic molecules. The development of an 
in vitro selection technique which enabled the screening of function-
ally improved synthetic catalytic biomolecules brought about a revo-
lution in this field. These biomolecules are screened from a chemically 
synthesized pool of oligonucleotides generated through combinato-
rial chemistry [2,3]. 
After many research efforts, Breaker and Joyce [4] successfully 
invented the first DNAzyme. Eventually, DNAzyme-based research 
gained momentum, stimulating the synthesis of a variety of DNA mol-
ecules that target a range of molecules [5]. Since then, numerous 
DNAzymes have been developed that catalyze a broad array of re-
actions, demonstrating them to be true biocatalysts alongside ribo-
zymes and proteinaceous enzymes, as shown in Figure 1.
In addition to the synthesis and mechanism of reaction catalyzed 
by DNAzymes, their significance in various healthcare applications has 
been increasingly emphasized. However, this field has not yet been 
critically reviewed. To date, there are only a few reports that have ad-
dressed the synthesis and applications of DNAzymes. Earlier reviews 
have focused on DNAzymes as biosensors, DNAzyme–nanoparticle 
(NP) conjugates, and DNA machines [6–8]. In this review we aim to 
combine all the important features related to the design of DNA-
zymes, the possible chemical reactions that can be catalyzed, and the 
exploration of current and future applications in healthcare. In the 
first part, we summarize the methodologies used for the synthesis of 
DNAzymes. In the next section, we discuss the different types of re-
actions that DNAzymes can catalyze, enabling selection of the best 
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Figure 1. Evolutionary Infographics and Pie Chart Analysis of DNAzyme. (A) Sche-
matic of the evolutionary lineage of a catalytic molecule. (B) Pie chart showing the 
percentage of published reviews in past decade featuring DNAzymes from the liter-
ature database (PubMed). About 86 reviews were found using keywords ‘DNAzyme’, 
‘DNA catalysis’, and ‘applications’. Abbreviation: XNA, xenonucleic acid. 
Kumar  et  al .  in  Trends  in  B iochemical  Sc i ences  44  (2019 )      6
DNAzyme for each of the desired applications. Finally, we highlight 
important applications of DNAzymes in sensing, therapeutics, molec-
ular devices, and nanodevices. In addition, barriers and future pros-
pects of DNAzymes are also discussed to aid future research efforts in 
this field. Overall, this review aims to provide a precise and clear view 
of DNAzymes, ranging from basic concepts to practical applications. 
Molecular Evolution of a DNA Molecule: A New-Age Catalytic 
Molecule 
DNA and RNA are naturally present as molecules of heredity but also 
have integral properties as catalysts. The most crucial feature of an 
enzymatic molecule is the positioning of functional groups to gen-
erate diverse 3D conformations. DNA duplexes have limited struc-
tural diversity because of their constrained 3D conformation, making 
double-stranded (ds) molecules less efficient at catalyzing biochem-
ical reactions. Moreover, the stability and the absence of 2′ hydroxyl 
from the sugar moiety of a DNA molecule make the dsDNA molecule 
less efficient when catalyzing a reaction. Therefore, ssDNA molecules 
have been explored as catalytic molecules [5]. 
A crucial feature of ss nucleic acids is that they can form composite 
2D or 3D structures by employing interdomain contacts. The gener-
ation of a variety of stabilized secondary structure conformations by 
ssDNA molecules has been widely demonstrated [9]. Researchers have 
mainly focused on the development of new functional DNA molecules 
(aptamers/DNAzymes) with the help of combinatorial chemistry. How-
ever, evolution of functionally active biopolymers from conventional 
polymers is not an easy task because their configuration imposes sig-
nificant hindrances, such as geometrical arrangement, stability, and 
functional complexity [10]. Unlike protein-based enzymes, DNAzymes 
can be easily synthesized using in vitro selection [6]. This is mainly be-
cause of the small 4n sequence space and the degeneracy of codons. 
Comparatively, protein molecules have a large sequence space of 20 
amino acids. Moreover, most common protein secondary structures 
such as a-helices and b-sheets are unstable if they fail to adopt ter-
tiary conformations due to the inherent cooperative nature of fold-
ing domains. By contrast, the secondary conformations adopted by 
ss nucleic acid molecules (e.g., hairpins and stem-loops) are relatively 
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stable. Another important factor is the availability of biochemical tools, 
such as DNA polymerases, reverse transcriptases, and RNA polymer-
ases that facilitate the synthesis and design of new DNAzymes. These 
molecular tools are readily available for nucleic acid catalysts, but not 
for the selection of synthetic protein sequences. 
In addition, DNAzymes are also favored as catalysts over RNA-
zymes due to their in vivo stability [11]. The presence of a carbon–
hydrogen (C–H) bond at the 2′ position of the sugar moieties of 
DNAzymes confers increased stability and reduced reactivity. DNA-
zymes are also less expensive than RNAzymes and can be easily syn-
thesized because there is no need for elaborate steps such as reverse 
transcription. These factors favor the in vivo performance and im-
plementation of DNAzyme for various healthcare applications. The 
merits and demerits of different catalytic molecules are described in 
Table 1. Moreover, DNA-based enzymes can further contribute to 
advances in nucleic acid chemistry, especially through the synthesis 
of artificial enzymes. Synthetic genetic polymers, known as xenonu-
cleic acid (XNA) with ameliorated stability, can fold into a definite 
specific conformation capable of forming the catalytic unit ‘XNA-
zyme’ [12]. Nonetheless, it should be noted that DNA enzymes are 
now active areas of research that are being investigated for techno-
logical applications.
Table 1. Comparison of Merits and Demerits between Protein Enzymes, RNA-
zymes, and DNAzymes to Evaluate the Best Catalytic Molecule 
Order  Catalytic molecule  Merits  Demerits 
1  Proteins  Stabilized transition state Require coenzyme for catalysis   
  Diversity of functional groups  Unstable secondary structure  
  Very high rate of reaction  Random sequence generation is   
         troublesome    
    Large size 
2  RNAzymes  New catalytic molecule through  In vivo stability 
     in vitro selection   More complex design owing 
  Possible secondary and tertiary     to reverse transcription step  
     conformations     
  Chemical and enzymatic stability  
  Minor batch variation 
3  DNAzymes  Chemically more stable  Research is still in progress   
  Inexpensive  Limited structural information  
  Easy synthesis  
  Easy to modify for systemic delivery
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A Combinatorial Selection Method, SELEX, To Synthesize New 
Catalytic DNA 
Combinatorial chemistry is a novel method to construct libraries that 
contain an astronomically large number of different but structurally 
similar molecules. Progress in this field has led researchers to employ 
combinatorial chemistry for the synthesis of a large number of unique 
and rare compounds of industrial significance [6]. Current challenges, 
such as the synthesis of catalytic molecules using genetic elements, 
connect two promising fields of modern science (i.e., combinatorial 
chemistry and molecular biology). SELEX is a combinatorial chemistry-
based in vitro selection method used for the synthesis of DNAzymes. 
The fundamental concept behind this approach is that the desired 
molecule may be found among a given pool of arbitrary sequence 
molecules, but identifying and isolating these rare desired molecules 
is challenging. The basic protocol of SELEX starts with a large pool of 
random sequences, followed by a multiple selection scheme involv-
ing separation methodologies and the amplification of selected se-
quences (Figure 2). 
Designing a good combinatorial library is a key step in the selec-
tion of specific catalytic molecules (Box 1 overviews factors that in-
fluence the selection of DNAzymes). The library of optimized mole-
cules is then incubated with the ligand of interest, followed by elution 
of bound oligonucleotides. Pools enriched in the molecules of inter-
est are then further separated using a range of partitioning methods. 
Different types of separation methodologies such as (i) filtration, 
(ii) electrophoresis, (iii) chromatography, and (iv) magnetic separa-
tion were exploited to separate target specific aptamers from opti-
mized libraries. Among these separation techniques, chromatogra-
phy has been used most often for the selection process because it 
can offer high selectivity and specificity [13]. The selection and puri-
fication procedure is then repeated multiple times, and the numbers 
of selected aptamers are reduced with each cycle of selection. Hence, 
conventional SELEX requires a timeframe of months for the genera-
tion of the desired final molecule [14]. 
After binding and separation, selected molecules are amplified, 
and PCR is used for the amplification of DNA and RNA [5]. SELEX is 
thus a repetitive process that includes binding, separation, and the 
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amplification of selected molecules. Optimally, 15–20 rounds of selec-
tion and amplification have been suggested for the initial identifica-
tion of target molecules; however, the reliability of single rounds as an 
alternative to conventional SELEX has been demonstrated by many re-
search groups [14]. In addition, advances in substituent methods have 
recently gained momentum for the selection of desired molecules 
[15–17]. Refinement of the strategy has focused on crucial steps in the 
Figure 2. Schematic Demonstration of the Selection of DNAzyme/Aptamer Mole-
cules Using the Conventional SELEX (Systemic Evolution of Ligands by Exponential 
Enrichment) Process. The selection process involves multiple steps such as (i) pool of 
ss DNA incubated with target molecules for selective binding, (ii) elution of bound 
sequences through different separation techniques, (iii) amplification of eluted se-
quences, and (iv) analyzing the best sequences by sequencing after 15-20 rounds. 
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Box 1. Key Factors Influencing the Design and Synthesis of DNAzymes 
Nucleotide Sequence 
A 20–60 nt random sequence is thought to be optimal for the synthe-
sis of DNA aptamers [117]. Although longer sequences allow more com-
plex structures to be generated, they can form self-aggregates, resulting 
in precipitation upon prolonged incubation. By contrast, smaller nucleo-
tide sequences have less likelihood of generating the desired sequences 
owing to limited structural diversity. Short oligonucleotide pools can be 
generated using the basic phosphoramidite chemical method, which has 
advanced further with automated solid-phase DNA synthesis machines 
[118]. The synthesis of much larger oligonucleotides (>100 nt) is a more 
challenging process. The most appropriate techniques are based on the 
incorporation of precise mutations into cloned sequences or on enzy-
matic synthesis (ligation-based synthesis and PCR-based approaches) 
[119]. More advanced technologies based on microarray systems (e.g., 
photolithography, microfluidics, and microchips) [120] can also be used 
for oligonucleotide synthesis. These new methodologies can not only 
lead to a reduction in cost and time but also generate longer sequences. 
Secondary Structure 
The degree of secondary/tertiary structure is another important fac-
tor because it is related to the generation of the binding site [121], and 
high-affinity aptamers can require a more complex structure. Compu-




junctionbecausethiscanaffectthefolding,cleavagerate, binding affinity, 
and, most importantly, the probability of producing an effective 8-17 
DNAzyme motif [121,123]. 
Fixed Flanking Sequences 
Specific structural sequences flanking random regions, such as 
primer-binding sequences and RNA domains, have been employed for 
the amplification of selected oligonucleotide sequences [124]. The ad-
dition of an RNA domain within the random DNA sequence increases 
the likelihood of occurrence of the desired catalytic molecule. There are 
several factors that must be considered when designing and optimizing 
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conventional SELEX process, including different methods of immobi-
lization, separation, removal of unwanted aptamer molecules, quan-
tification, binding efficiency, real-time monitoring, and many more. 
Current Emerging Concepts of the SELEX Technique 
For a long time researchers considered prototypical methods such 
as negative, counter, blended, and toggle SELEX (Table S1 in the sup-
plementary information online) as efficient techniques for the se-
lection of DNAzymes. These classical methods are still the basis of 
high-throughput screening processes. Most current SELEX applica-
tions utilize multiple methods that are suitable for diverse classes 
(Figure 3). Major forms of SELEX which have recently gained mo-
mentum are acclimatizing techniques such as microarrays, sequenc-
ing, and microfluidics. 
these constant regions, such as the formation of primer dimers, second-
ary structure formation, length, and GC content. 
Target Concentration 
An optimal target concentration is used to avoid nonspecific binding 
and to improve the efficiency of the SELEX selection procedure. Various 
strategies have been proposed and successfully exploited, including (i) 
addition of spacer molecules that can change the length of aptamers, 
(ii) coupling with a fluorescent molecule, and (iii) incorporation of un-
natural bases that can help to increase the diversity of catalytic mole-
cules [80–82,124,125]. The impact of optimal target concentration and 
nonspecific binding has been assessed in relation to the efficiency of 
the selection process [126]. 
Underestimating anyone of these parameters may lead to undesirable 
results. Therefore, it is very important to establish an optimal value for 
the above-mentioned factors during the iterative process to ensure that 
quality results are obtained. 
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Cell-SELEX 
The original SELEX method utilizes purified proteins as targets for 
the selection of high-affinity aptamers. An important issue related to 
these aptamers was their low performance in clinical trials. The rea-
son is the inability of aptamers to bind native proteins because they 
adopt a different conformation in vivo. In view of such findings, a new 
concept of a complex native molecule as a SELEX target came into ex-
istence. Later, it was applied to further upgrade the methodology for 
selection against whole cells [18]. However, a major challenge arises 
while performing cell-SELEX of aptamers against multiple targets, and 
counterselection is essential to avoid nonspecific binding. The cor-
rect choice of target cell and control cell is also an important factor 
to be considered while carrying out cell-SELEX. The cell-SELEX pro-
cess does not require elucidation of the molecular markers on the tar-
get cell surface, which further simplifies the in vitro selection method. 
Indeed, the whole SELEX process is a basic, rapid, reproducible, and 
Figure 3. Historical Evolution of Key SELEX Processes. This scheme shows major 
SELEX methodologies from their discovery (i.e., Negative SELEX) to present ad-
vancements (i.e., Hi-fidelity SELEX). 
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direct approach to generate high-affinity aptamers in the nanomo-
lar-to-picomolar range [19]. Cell-SELEX is hence an attractive strategy 
for implementation in diagnostic applications. 
A major concern in terms of modern healthcare is to devise and 
implement therapeutics for cancer. Cell-SELEX can be utilized for the 
enrichment and identification of aptamers targeting cancer cells [18–
20], and the technique can be extended to diverse targets including 
stem cells, virus-infected cells, and bacterial cells [21–23]. It can also 
be used to identify new biomarkers and drug targets for the treat-
ment of major diseases [24]. 
Cell-SELEX holds high potential in healthcare applications, but there 
are some limitations that constrain the affinity of the aptamer mol-
ecules identified. For example, the presence of dead cells in the tar-
get preparation can adversely affect the selection procedure and can 
result in nonspecific DNA molecules. In addition, (i) difficulties in the 
identification of targets due to the complex nature of the cell mem-
brane, (ii) reduced binding affinity because of the repulsive force be-
tween a negatively charged DNA molecule and similarly charged cell-
membrane components, and (iii) separation of the binding complex 
is not efficient because the target cells are not fixed [20]. However, 
numerous efforts have been made by researchers to overcome these 
limitations and to further optimize the technology. Optimization of 
the methodology contributed to the development of a more efficient 
version of cell-SELEX that offers a glimpse of fast and current research. 
Raddatz et al. eliminated dead cells using fluorescence-activated cell 
sorting (FACS), and named the method FACS-SELEX [25]. In compar-
ison to other existing methods, this technique requires less time to 
complete, mainly due to the synchronous execution of both positive- 
and negative-selection steps. Cell- internalization SELEX [26] is ca-
pable of selecting aptamers that can deliver drugs directly into the 
cytoplasm of the target cells. Aptamers slow in internalization were 
eliminated using stringent washing. The major issue with this method 
is the choice of target cells (i.e., a cell line over- expressing the tar-
get protein) and a comparable negative cell line. Evolution of the in-
ternalization methodology increased the efficiency of cell-SELEX, al-
though it remains a cumbersome procedure. 3D cell SELEX [27] was 
recently developed based on a 3D cell culture, employing magnetic 
levitation technology, that mimics the tissue microenvironment under 
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in vitro conditions. These studies suggest that the technology is im-
proving day by day to promote the widespread use of SELEX in health-
care applications. 
In Vivo SELEX 
Although the SELEX approach has been employed to enrich for 
aptamers targeting either purified substrate or cells expressing the 
target of interest, the conditions employed did not accurately reiter-
ate the in vivo configuration and stability. As a result, therapeutic ap-
tamers did not perform ideally under in vivo conditions. The in vivo 
stability of aptamers is of utmost importance in the context of ther-
apeutics, and in vivo SELEX methodology has been demonstrated to 
select highly stable and active aptamers within the living cell environ-
ment [28]. This approach has many advantages for clinical research, 
and many research groups have used this technology to select ligands 
targeting different diseases, especially tumors [29] as they can selec-
tively localize and inhibit diseased tissue while helping to decrease 
the level of pharmacologic optimization. 
Another important task in therapeutics is to discover drugs that 
can penetrate the blood–brain barrier (BBB). In vivo SELEX has been 
used in conjunction with artificial BBB cell culture to select aptamers 
that can be delivered to the brain [30,31]. However, more rounds of 
selection are necessary to obtain the desired aptamers, making the 
system more complex. Further improvements can be achieved by us-
ing a smaller library to reduce the number of rounds of selection that 
are required, or by conjugation to NPs to improve delivery [32]. The 
combination of in vitro and in vivo SELEX can be more appropriate 
for designing aptamers. This approach enabled the real-time detec-
tion of aptamer-binding targets in live cells, and has potential in many 
healthcare applications [33]. 
Toggle SELEX 
The toggle SELEX method follows the conventional strategy but 
employs multiple targets. Rotation of targets during screening allows 
the selection of ligands for conserved domains of related targets, and 
has facilitated the selection of catalytic molecules for healthcare ap-
plications [22,23] where crossreactivity may enhance in vivo viability 
because preclinical evaluation of therapeutic molecules sometimes 
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fails due to low in vivo efficacy. Since, clinical trials require crossre-
activity to diagnose multiple targets toggle SELEX can be extremely 
helpful for drug discovery. 
To exploit the toggle strategy in the selection of ligands that favors 
crossreactivity, the target should be properly selected. A larger surface 
area leads to the selection of sequences against various sites of a tar-
get, some with lower affinity and others with higher affinity, while tar-
geting individual epitopes often results in a weakly interacting mol-
ecule. Toggle SELEX was applied for the generation of aptamers that 
have broad specificity for different clinical isolates of influenza virus 
[22]. Very recently, in light of the potential benefits of toggle SELEX, 
it has been used for the selection of an aptamer that can target dif-
ferent Gram-positive and Gram-negative bacteria [23]. 
High-Throughput SELEX 
For high-throughput screening of combinatorial libraries, kinetic 
capillary electrophoresis-based methods, such as nonequilibrium cap-
illary electrophoresis of equilibrium mixtures (NECEEM), equilibrium 
capillary electrophoresis of equilibrium mixtures (ECEEM), and sweep-
ing capillary electrophoresis (SweepCE), have been employed for the 
selection of catalytic molecules [34]. These methods were primarily 
based on the separation of a mixture containing an oligonucleotide 
and the target using gel-free capillary electrophoresis. To further in-
crease the efficiency of CE-SELEX, a fraction collection approach has 
been integrated into a newer version named FCE-SELEX. The most 
striking feature of FCE-SELEX is its ability to select aptamers in a sin-
gle round of selection [35]. 
A particle display bead-based method has also been used for high-
throughput selection of high-affinity aptamers [36]. In this method, 
instead of immobilizing target molecules, the aptamers are used as 
the stationary phase. For this purpose, each aptamer is converted 
to aptamer particles using emulsion PCR. Subsequently, these ap-
tamer particles are selected against a fluorescent-labeled target and 
screened by FACS. 
These high-throughput selection methods are currently widely used 
to produce aptamers against different molecules [34,37,38] and have 
been suggested as a highly rapid and economical method for the gen-
eration of catalytic molecules. 
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Microfluidic SELEX 
Microfluidics is a discipline of science that deals with the use of 
fluids at the microlevel to achieve automated and high-throughput 
point-of-care devices. In microfluidics SELEX, micro-volumes of target–
DNA mixtures are passed through microfabricated channels and fur-
ther separated using a high-voltage current [39]. This technique can 
be operated continuously for a long time to isolate conjugates with 
low mobility and with low dilution of samples. It has been assumed 
that reducing the number of target molecules may lead to the identi-
fication of aptamers with higher affinity. In addition, the short transit 
time enhances the applicability of the method, and this microsystem 
provides a rapid and effective screening protocol for aptamers with 
potential diagnostic applications [40–42]. 
Automated SELEX 
Automation can ensure superior reproducibility, and several differ-
ent molecular methods (e. g., sequencing, PCR, and microarrays) have 
already been automated. Consequently, this resulted in ease of tech-
niques by simply reducing the time needed for manipulation and ar-
rangements. Because SELEX is a very time-consuming and repetitive 
process, automated versions were developed and used to select cat-
alytic molecules against different types of targets [43]. A major lim-
itation is that, so far, automated SELEX can only be used for a single 
target. Hence, there is a need for an approach to multiplex target. Re-
cently, an automated microcolumn-based 96-well plate device, ME-
DUSA, was developed that can process aptamer selection for multiple 
targets [44,45]. An improved version of high-throughput SELEX com-
patible with automation was also demonstrated by Gopinathan et al. 
[46]. However, fully automated frameworks require consistent integra-
tion of processes and design (e.g., software development, fabrication 
of instruments, and installation), and their operation requires signifi-
cant expenditure and maintenance. 
Semi-automated SELEX may have advantages in the selection of 
high-specificity aptamers. To maintain versatility, the initial selection 
steps are performed manually, but a robotic mechanism is employed 
for subsequent steps such as PCR amplification, ultrafiltration, and 
fluorescence detection. Many semi-automated workstations for the 
SELEX process have been reported. Hunniger et al. recently developed 
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a semi-automated SELEX [47] platform in which the first few steps of 
SELEX, including incubation and elution of aptamer sequences, are 
carried out by an automated deep-well plate ‘FISHing’ procedure. 
These eluates were then amplified using solid phase-emulsion PCR 
in a process known as ‘BEAMing’. This allowed simultaneous selec-
tion of aptamers against a variety of targets. A rapid automated ap-
proach that is less costly is chip-based microfluidic SELEX which per-
mits miniaturization of the SELEX system [39]. Although chip-based 
automation is much more accessible, further developments of related 
technologies are needed. 
Nanoselection-Based SELEX 
Nanotechnology is currently widely applied in a variety of fields, in-
cluding healthcare, materials science, and molecular biology, because 
it offers several advantages such as small size and large surface area, 
optical and electrical properties, stability, and biocompatibility [48]. 
Convergence of nanotechnology with functional molecules has led 
to further breakthroughs in the field of healthcare [49–51]. Diverse 
NPs, including quantum dots (QDs) [52], gold NPs (AuNPs) [53], and 
polymeric NPs [54], have been used for bioconjugation to DNAzymes. 
Another technique that has been incorporated into SELEX to im-
prove the selection of aptamers is microscopy _ for example, stimu-
lated emission depletion microscopy (STED) and laser confocal flu-
orescence microscopy (LCFM) [55,56]. One highlight of this strategy 
is that it allows extraction of a single aptamer molecule. PCR ampli-
fication of these single-selected aptamers allows direct sequencing, 
thus eliminating several laborious steps of the SELEX procedure such 
as cloning and purification. This approach is still under development 
because it cannot be applied to a large pool of oligonucleotides. This 
technique offered a new method of aptamer selection in an excep-
tionally short period of time. These new-age microscopy techniques 
will be particularly helpful for aptamer libraries based on chemically 
modified nucleotides. 
SELEX is an important tool for the selection of functional DNA mol-
ecules. Numerous investigations and research studies have been car-
ried out to make it more efficient, quick, and selective to generate 
more modified versions of SELEX. Although SELEX was initially devel-
oped for the selection of DNA/RNA aptamer molecules, modification 
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of the technology has allowed selection of functional nucleic acid-
based catalytic molecules. File S1 (supplemental information) sum-
marizes all SELEX methods available to date with a brief explanation 
of their basic principles. 
DNAzyme-Catalyzed Reactions 
DNAzyme-catalyzed reactions constitute a new area of biological re-
search. Despite the fact that there are only four nucleobases, DNA-
zymes can facilitate a wide range of reactions (Boxes 2 and 3), includ-
ing cleavage and ligation of DNA or RNA [57,58], RNA branching [59], 
synthesis of nucleopeptide bonds [60], phosphorylation [61], depurina-
tion, adenylation, and porphyrin metallation of DNA [6,62] (Figure 4). 
These reactions further helped in understanding the potential of DNA 
as a catalytic molecule. Moreover, DNAzyme-catalyzed reactions gen-
erally require specific cofactors, principally metal ions, for catalysis [7]. 
The group of Silverman [6] further extended the spectrum of DNA-
zymes through the development of newer catalytic molecules. For ex-
ample, DNAzymes catalyzing phosphatase, phosphoserine lyase, and 
ester/ amide hydrolase reactions have interesting future prospects in 
biotechnological applications. 
Structural Analysis of DNAzymes 
The crystal structure of a molecule is a 3D atomic configuration that 
corresponds to the lowest state of energy. DNAzymes have been 
shown to have a well-defined 3D conformation [63], and their de-
tailed structures give insights into the interaction between the DNA-
zyme and the substrate molecule and have been applied to the de-
sign of DNAzymes for other catalytic reactions. 
DNAzymes are typically classified as metallozymes, but crystallo-
graphic studies have revealed that metal ions are generally absent 
from the catalytic active site, although bound metal ions were found 
to induce additional folding [64]. This will further influence research 
to develop novel cofactor-independent DNAzymes. These observa-
tions confirmed that structural and mechanistic analysis is necessary 
to assess the complete potential of DNAzymes. Although attempts 
have been made to study the crystal structures of DNAzymes, more 
research in this area is needed. 
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Box 2. DNAzyme Promiscuity for RNA/DNA Cleavage and Carbon–
Carbon Bond Formation 
DNAzymes that catalyze the cleavage of RNA are by far the largest class 
of catalytic DNA molecules. RNA cleavage invariably depends on nucleo-
philic attack of a phosphorous linkage by the 2′-hydroxyl of the adjacent 
ribose sugar [6]. This results in the formation of 2′,3′-cyclic phosphate and 
a 5′-hydroxyl group at the cleavage site. The basis of catalysis appears to 
be similar between synthetic DNAzymes and naturally occurring RNA-
zymes. The very first DNAzyme, GR-5 [4], was an RNA-cleaving DNA-
zyme, and such DNAzymes can increase the rate of target cleavage by a 
factor of 1010. However, DNAzymes are generally dependent on a metal 
ion cofactor for their enzymatic activity. The two most common types of 
DNAzymes discovered since GR-5 contain are 10–23 and 8–17 motifs [7]. 
DNAzymes of the 8–17 type are the most thoroughly studied because they 
can cleave multiple types of RNA substrate. The presence of a guanine–
thymine (G–T) ‘wobble’ base pair downstream of the cleavage site is in-
dispensable for the catalytic activity of the 8–17 DNAzyme, and replace-
ment of the wobble pair by a Watson–Crick pair at this position abolishes 
the cleavage reaction. This DNAzyme sequence arrangement recurs very 
frequently during the selection against various targets owing to its small 
size. More recently, efforts have been made to develop RNA-cleaving 
DNAzymes that function in the absence of metal ion cofactors [127], and 
protonated nucleotides of DNAzymes have been found to induce cata-
lytic reactions. Subsequently, DNAzymes using organic cofactors such as 
histidine for catalytic activity have also been reported [58]. 
The development of DNA-cleaving DNAzymes was promoted by the 
need for synthetic DNA-based nucleases which would have wide appli-
cations in DNA cloning. The DNAzyme 10MD5 was found to cleave the 
target phosphodiester linkage specifically at the sequence ATG^T in the 
presence of metal ion cofactors Mn2+ and Zn2+ [7,128]. 
Diels-Alder Reaction 
DNAzymes can also catalyze the formation of carbon–carbon (C–C) 
bonds [7]. The Diels–Alder reaction involves a reaction between anthra-
cene (a conjugated diene) and maleimide derivatives (alkene) to form 
9,10-dihydroanthracene-9,10-α,β-succinic anhydride, and these anthra-
cene-imide derivatives have a wide range of applications in chemical 
biology. Because C–C bond formation is a fundamental reaction of all 
synthetic organic chemistry, bioenzymes are attracting much interest 
in this field. 
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Box 3. DNAzyme-Mediated Catalysis of Other Types of Biochemical 
Reaction 
Ligation 
DNAzymes can catalyze the nonnative 2′–5′ linkage because this does 
not require high-energy substrates. The mechanism of RNA ligation is to 
form a bond between a 2′,3′-cyclic phosphate and a 5′-hydroxyl [7]. De-
spite success in bridging the two fragments using a DNAzyme, there is a 
need for potential alternative methodologies that can lead to native 3′–5′ 
linkages. Subsequently, numerous studies successfully demonstrated the 
creation of native 3′–5′ phosphodiester linkages in the presence of metal 
ion cofactors using DNAzyme catalysis. These DNAzymes ligate with a 
high rate of reaction. Since then, research has focused on how to generate 
DNAzymes that are capable of catalyzing all possible ligation reactions. 
Branching 
DNAzymes have been identified catalyzing formation of a 2′–5′ 
branched RNA by reaction between an internal 2′- hydroxyl group of 
one oligonucleotide and a terminal 5′-triphosphate group of another 
[6]. Examples of deoxyribozymes that can create 2′,5′ branched RNA se-
quences include 10DM24, and 7S11. The DNAzyme 7S11 branching en-
zyme can catalyze a reaction using the three-helix junction approach. 
In this approach, the DNAzyme selectively recognizes a single unpaired 
adenosine nucleotide in one substrate molecule, which further induces 
a nucleophilic reaction between the 2′-hydroxyl of adenosine and the 
α-phosphate of the other RNA substrate. Deoxyribozymes can also cat-
alyze lariat RNA (closed loop at termini) reactions. The major mechanism 
of such reactions is similar to the formation of a looped byproduct dur-
ing splicing of nascent mRNA after transcription. In addition, DNAzymes 
catalyzing synthesis of branched DNA have also been isolated. These re-
cently reported new DNAzymes have great potential in catalytic research. 
Nucleopeptide Linkage 
A DNAzyme has been isolated that catalyzes the formation of ty-
rosine–RNA nucleopeptide linkages [6,7]. This DNAzyme was derived 
by reselection from the 7S11 DNAzyme in which tyrosine replaced the 
branch-site ribonucleotide while maintaining the three-helix junction in-
terface. This 7S11 variant DNAzyme employed GTP for substrate-level 
phosphorylation. 
DNAzymes that are able to act on small-molecule substrates still need 
to be identified, and DNA aptamers with high affinity for a broad range 
of molecules are a focus of ongoing research. 
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Emerging Applications of DNAzymes 
Since the first invention of DNAzymes, these catalysts have become 
a hot topic of research. In addition to inherent academic interest in 
DNAzyme-mediated catalysis, research in this field has fostered ap-
plications across a wide range of scientific disciplines, including mo-
lecular biology tools, therapeutics, sensing, and nanomotors. Some 
applications are of immediate practical utility (such as the use of RNA-
cleaving DNAzymes as in vitro endoRNases), whereas others remain to 
be validated. However, in the future, innovative research might over-
come additional obstacles before they can be used productively. In 
this section we address the potential utility of DNAzymes in various 
applications. 
Figure 4. Schematic of Different Reactions Catalyzed by DNAzymes. Catalytic ac-
tive DNA sequences are represented by green line with loop. Binding of DNAzyme 
can catalyze (i) cleavage, (ii) ligation, (iii) branching, (iv) phosphorylation, and 
(v) metallation reaction. 
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DNAzymes as Biosensors 
The development of biosensors to detect a specific analyte gen-
erally involves the integration of biological molecules with a signal 
transducer. Biosensors are highly dependent on the dynamics of the 
target molecule. Given their enhanced selectivity, stability, and high 
affinity (often in the picomolar to nanomolar range), DNAzymes have 
also been explored as biosensors. The introduction of reporter mol-
ecules into nucleic acid-based functional molecules (aptamer/ DNA-
zymes) can be easier than for other molecules. The first DNAzyme-
based fluorescent biosensor evolved from one of the most remarkable 
DNAzymes, 8-17, which employs metal ion (Pb2+)-dependent RNA-
cleavage activity for biosensing [65]. These biosensors can offer ex-
quisite sensitivity and selectivity. Consequently, multiple types of sen-
sors have been developed by combining DNAzymes with different 
signal-detection techniques (optical, piezoelectric, and electrochem-
ical). Since then, numerous DNAzyme biosensors have been invented 
for the effective detection of diverse metal ions, such as Cu2+, Pb2+, 
Hg2+, UO22+, and K+, using simple engineering methods. 
Optical Aptasensors 
An optical aptasensor is a device that converts light rays into an 
electronic signal. Optical sensing is further classified as fluorescent, 
colorimetric, or chemiluminescent sensing. Fluorescent sensing is 
among the most widely used method due to its excellent sensitiv-
ity/ selectivity, reproducibility, broad linear dynamic range of detec-
tion, and simple operational procedure. Because fluorescence is not 
an inherent property of DNAzyme molecules, incorporation of fluo-
rophore molecules into the functional DNA molecules is essential to 
obtain fluorescence properties. DNA-based fluorescent sensors can 
be comprehensively characterized into labeled and nonlabeled sen-
sors (Box 4). Nonlabeled aptasensors are generally less expensive and 
more straightforward to use. In addition, because there is no risk of 
binding-site modification, they tend to be more popular than labeled 
aptasensors. This approach has been applied by many groups to de-
velop an array of label-free biosensors against a vast range of target 
molecules (Table 2) [66–70]. These DNAzyme-based biosensors are of 
great interest for real-time detection of heavy metals in water samples. 
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Box 4. Different Types of DNAzyme-Based Biosensors 
Nonlabeled Fluorescent Sensors 
These sensors employ dyes, polymers, NPs, or nanoclusters for binding to aptamers. In-
tercalating dyes such as PicoGreen have been investigated for aptamer binding in sensor ap-
plications [129]. Among the different types of conjugated polymers, water-soluble polymers 
[e.g., poly(2,5-bis(3-sulfonatopropoxy)-1,4-phenylethynylenealt-1,4-poly(phenylene ethyn-
ylene), PPESO3] with fluorescent properties have been widely explored for use in biosensors 
[130], and an array of label-free biosensors have been developed against a range of target 
molecules. 
Fluorescent-Labeled Sensors 
Designing labeled aptasensors involves covalent attachment of fluorophore molecules 
to the target-binding sites of aptamer molecules [69]. Fluorescent nucleotide analogs have 
been explored in the development of aptamer sensors [131] because they are unlikely to af-
fect binding affinity. These types of signaling aptamers can display an increment in fluores-
cence of up to 30-fold upon target binding. NPs can also be used instead of fluorescent dyes 
in the development of aptasensors. AuNPs and other metallic NP-based biosensors have 
been designed for a variety of targets, including cancer cells, bacterial species, and many 
proteins [69,132]. QDs take into account multiplex detection of different analytes in parallel 
because they can respond to similar excitation wavelengths while transmitting at different 
wave-lengths [71]. Graphene oxide and CNTs have attracted increasing interest in the devel-
opment of DNAzyme-based biosensing frameworks because they are super-quenchers with 
long-range nanoscale energy-transfer properties for fluorescent assays [133]. 
More recently, different fluorescence modules have been developed for applications in 
real-time detection. The bichromophore approach is commonly used for fluorescence-based 
DNAzymes [68,70], and amplification methodologies such as PCR and RCA have also been 
investigated to enhance the detection limit of fluorescence-based aptasensors. In this re-
spect, immuno-PCR (IPCR) has been proposed as a promising technique for the future [134]. 
Colorimetric Aptazyme Sensors 
AuNPs and G-quadruplex aptamers have substantially contributed to the development of 
colorimetric biosensors because they have extremely high extinction coefficients. AuNPs also 
display surface plasmon resonance (SPR), an interparticle distance-dependent optical prop-
erty. Cationic polymers have also been investigated for application in colorimetric aptasensors 
[135]. AuNPs are crosslinked to aptamers to form an aggregate, which, upon binding to the 
target molecule, dissociates to produce a color change [136]. Another mode of using AuNPs 
in colorimetric biosensing is a noncrosslinking approach. AuNPs are initially crosslinked to 
aptamer molecules such that they remain present in a dispersed state in a solution. Binding 
of the aptamer to the target molecule leads to dissociation from AuNPs, and the free AuNPs 
then form aggregates, leading to a color change. The rapid colorimetric aptasensor devel-
oped for Pb2+ was inspired by the same noncrosslinking approach [137]. 
Kumar  et  al .  in  Trends  in  B iochemical  Sc i ences  44  (2019 )      24
For catalytic beacon sensors, one of the major drawbacks is back-
ground fluorescence. Such background occurs mainly due to non-
specific dehybridization of the enzyme and the target substrate. To 
combat these issues, immobilization of catalytic molecules has been 
reported, and this resulted in a >10-fold improvement of the detec-
tion limit. QDs were first chosen because they have greater photosta-
bility, larger Stokes shifts, and longer fluorescence periods [71]. How-
ever, NPs (e.g., iron oxide, gold, and manganese oxide) (Box 4) have 
been preferred for direct conjugation with DNAzymes because they 
have lower toxicity. 
The fluorescence signals generated can be monitored using differ-
ent systems such as anisotropy, bichromophores, fluorescence reso-
nance energy transfer (FRET), and antisense con-formational triggers 
[68,70]. The detection sensitivity of DNAzyme-based point-of-care de-
vices can be enhanced by incorporating advanced techniques such as 
real-time PCR and rolling circle amplification (RCA) (Box 4). Recently, 
reduced graphene oxide was integrated with RCA to further increase 
Table 2. List of Different Types of DNAzyme-Based Biosensors 
Type of sensor  Biomimetic component  Reporter molecule  Analyte of interest  Reviews 
Nonlabeled fluorescent sensor  Horseradish peroxidase  Hemin  Potassium ion (K+)  2012 [66] 
    metallozyme-imitating  
    DNAzyme  
    (HRP-DNAzyme)   
 DNAzyme  SYBR Green  Copper ion (Cu2+)  2013 [67]  
 G quadruplex  Thioflavin T (ThT) dye  Lead ion (Pb2+)  2016 [68] 
Labeled fluorescent sensor  DNAzyme  FAM  Sodium ion (Na+)  2015 [70]  
 DNAzyme  QDs  Pb2+  2011 [71]  
 GR-5 DNAzyme  Graphene oxide  Pb2+  2011 [133]  
 DNAzyme  Metal ion-modulated graphene  Pb2+  2011 [138]  
 DNAzyme  Crosslinked AuNPs  Pb2+  2003 [136]  
 DNAzyme  Noncrosslinked AuNPs  Adenosine  2004 [137] 
Colorimetric aptasensor  DNAzyme  Unmodified AuNPs  Pb2+  2012 [139]  
 G quadruplex DNAzyme  Peptide/Au nanocomposites  ATP  2014 [140]  
 G quadruplex DNAzyme  N-Methyl mesoporphyrin IX (NMM)  Pb2+  2012 [74]  
 G quadruplex DNAzyme  Hemin  miRNA  2017 [77]  
 G quadruplex DNAzyme  ABTS  Choline  2018 [79]  
 DNAzyme  Hemin  ochratoxin A (OTA)  2014 [80]  
 DNAzyme  Graphene oxide  Hg2+  2015 [83] 
Electrochemical sensors  DNAzyme  Gold (Au) electrode  Lead ion (Pb2+)  2008 [88]  
 DNAzyme  Gold (Au) electrode  Copper ion (Cu2+)  2017 [89] 
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the versatility and sensitivity of aptazyme sensors [72]. The method in-
cludes the release of primer-tagged ATP aptamers from graphene ox-
ide upon target binding as a result of conformational changes. These 
ATP aptamers were then amplified by RCA, and the limit of detection 
(LoD) could be improved by several orders of magnitude. 
Colorimetric sensing, another type of optical sensing, detects a 
change in color taking place upon binding. Currently, AuNPs and G-
quadruplex aptamers are most popular for the development of colori-
metric aptasensors [73] (Box 4). The sensitivity of colorimetric sensors 
can be superior to comparable optical fluorescence sensors because 
they take advantage of noncovalent interactions between dyes and ap-
tamers. The preparation of DNA-linked AuNPs is somewhat tedious, and 
scientists devised a new concept of unmodified AuNPs [74]. In this ap-
plication, NPs were stabilized using negative charge, which prevented 
them from aggregation, while van der Waals interactions allowed ss-
DNA to coil around the AuNPs. Upon interaction with target molecules, 
aptamers lost their ability to protect the NPs. Hence, they formed ag-
gregates, thus producing a color change. Likewise, AuNPs can be used 
in conjunction with aptamers against specific analytes [75]. 
G-quadruplex DNAzymes have also been tested for the develop-
ment of colorimetric bio-sensing. Such complex DNAzymes can cat-
alyze the oxidation of hydrogen peroxide that can be detected by 
chemiluminescence. This mechanism was employed for sensing any 
analyte by incorporating G-quadruplex in aptamers. The advantage 
of chemiluminescence as a detection unit in aptasensors is its unique 
zero background. The only limitation of the technique is the availabil-
ity of a few chemiluminescent compounds are available. These DNA-
zymes have been explored for the generation of chemiluminescence-
based biosensors against different targets (Table 2) [76–79]. 
Liu and colleagues worked on chemiluminescence resonance en-
ergy transfer (CRET)-based aptamer sensors. CRET is similar to FRET 
because it depends on transfer of resonance energy from chemilu-
minescent donors to QDs as acceptors. For CRET-based aptasensors, 
peroxidase-mimicking DNAzymes were conjugated to QDs [80]. The 
CRET principle was incorporated into many aptamers to further de-
velop the sensing platform [81]. In addition to QDs, other nanomate-
rials such as graphene oxide have been employed in chemilumines-
cent aptasensors [82,83]. 
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Electrochemical Aptasensors 
Another type of biosensor with a wide range of applications in 
healthcare and environmental analysis is electrochemical detection, 
and electrochemical procedures with enhanced sensitivities can be 
easily incorporated into point-of-care devices. The instrumentation of 
electrochemical sensors is straightforward and easy to use. Different 
electrochemical strategies have been used to measure the changes 
in current or voltage, including impedance spectroscopy, potentiom-
etry, electrogenerated chemiluminescence, voltammetry (cyclic/lin-
ear), and amperometry. 
A major advance in the field of electrochemical biosensors is the 
use of nanomaterials [e.g., gold and silver NPs, multiwalled carbon 
nanotubes (MWCNTs), and nanoconductive polymers] to improve sen-
sitivity, biocompatibility, and, more particularly, miniaturization [84,85]. 
Among them, appropriately functionalized carbon nanomaterials can 
be used to build superior electrochemical sensors with promising ap-
plications in diagnostics and therapeutics [86]. 
Electrochemical sensing strategies are further classified into two 
categories: labeled and label-free. The labeling methodology [87] re-
sults in high sensitivity and specificity. Electroactive compounds [e.g., 
ferrocene, ferrocyanide, methylene blue (MB), and QDs] were found to 
be more valuable labels for aptamer conjugation than were enzymes 
such as horseradish peroxidase, glucose oxidase, or acid phospha-
tase. Voltammetric pulse techniques [e.g., differential pulse voltam-
metry (DPV), square wave voltammetry (SWV), and alternating cur-
rent voltammetry (ACV)] were most commonly used for label assays 
because of their high signal-to-noise ratio. The labeled methodology 
was further sectionalized into switch-on and switch-off types, which 
differ in how the electrochemical signal is generated. In the switch-
on approach [87], target binding induces a conformational change in 
the structure of the aptamer molecule. This conformational change 
decreases the effective distance between redox species and the elec-
trode, leading to an increased electric current. By contrast, in the 
switch-off strategy [88] there is a significant separation between the 
electroactive compound and the electrode, prompting a reduction in 
the electrochemical signal. One particular example of the switch-off 
type is an electrochemical DNAzyme sensor for lead (Pb2+). Follow-
ing (label-free) aptamer–analyte binding, the electrochemical behav-
ior of intrinsic redox molecules (mainly guanine and adenine) at the 
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electrode surface is modified, and these redox changes can be accu-
rately detected by electrochemical techniques such as cyclic voltam-
metry, potentiometry, and electrochemical impedance spectroscopy 
(EIS) [89]. Electrochemical aptasensors have thus become an estab-
lished method for detecting analytes in clinical, environmental, and 
biological applications [87–91]. 
DNAzymes as Therapeutic Agents 
The conformational plasticity and targeting specificity of these func-
tional oligonucleotides make them a potential source of therapeutic 
molecules. DNAzyme-based biomedicine typically involves the mod-
ulation of downstream signaling of the desired target after binding 
to a functional molecule. Specifically, RNA-cleaving DNAzymes were 
described as promising therapeutic agents [92]. The vast majority of 
in vivo drug trials in the field have employed the remarkable deoxyri-
bozyme, 10-23, because it can act upon a vast array of cleavage sites. 
Cancer treatment is the main therapeutic application of DNAzymes 
because they can distinguish between healthy and tumorigenic cells 
[92]. Unlike other therapeutic strategies DNAzyme-based drugs have 
no adverse effects on healthy cells or on the maintenance of homeo-
stasis in the patient, DNAzymes have been used to target several key 
biological systems (Table 3), taking advantage of their specificity and 
stability under in vivo conditions. 
Table 3. List of DNAzyme Systems Used To Treat Different Types of Cancer 
S. no.  Type of DNAzyme  Molecular target present on cancer cell  Type of cancer  Ref. 
1  10–23 subclass  Early growth response protein 1 (EGR1) Breast cancer  [141] 
2  DZ509  EBV latent membrane protein  Nasopharyngeal carcinoma  [142] 
3  10–23  Hepatitis B virus X protein  Hepatocellular carcinoma  [143] 
4  DrzBS- and DrzBC-based   Hepatitis B virus s and e genes  Hepatocellular carcinoma  [144]  
    on the 10–23 model
5  Dz13 and As13  c-Jun  Skin cancer  [145] 
6  12–LOX  Lipoxygenase  Leukemia  [146] 
7  DT912  BCL-2 apoptotic protein  Prostate cancer  [147] 
8  Peroxidase-mimicking   Carcinoembryonic antigen (CEA)  Oral and salivary malignant  [148]  
    DNAzyme      tumors
9  DT433  DNA methyltransferases  Bladder cancer  [149] 
10  Drz2  AKT1 (protein kinase B)  Thyroid tumor  [150] 
11  Drz1 and Drz2  Surviving apoptotic protein  Breast cancer  [151] 
12  Drz1 and Drz2  Insulin-like growth factor-II (IGF-II)  Hepatocarcinoma  [152] 
13  AM9D  MMP9 (matrix 2metalloproteinase)  Breast cancer  [153] 
14  DT18 Vascular endothelial growth factor (VEGF)  Multiple myeloma  [154] 
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More extensive biomedical implementation of DNAzymes will re-
quire highly efficient and biocompatible delivery systems. Nanocom-
posites hold great promise [93,94] because they offer many additional 
benefits: (i) high drug encapsulation efficiency, (ii) sustained delivery 
avoiding the premature release of drugs, (iii) ability to surmount dif-
ferent biological barriers, and (iv) specific targeting. In addition, these 
nanocarriers are highly biocompatible because they are nontoxic and 
have low immunogenicity. A growing list of NPs and their conjugates 
have been developed for healthcare applications, for example iron 
oxide NPs (IONPs), AuNPs, QDs, carbon nanotubes (CNTs), PBE func-
tionalized graphene oxide, and Fe3O4/poly(D,L-lactide) (PDLLA) nano-
composites [93–96]. The advantageous properties of DNAzymes favor 
their conjugation to nanocarriers for high-efficacy therapeutics [97], 
and several DNAzymes have been explored in the treatment of dif-
ferent types of cancer (Table 3). 
DNAzymes have also been developed to treat viral diseases, in-
cluding HIV and hepatitis infection [98,99]. DNAzymes targeting dif-
ferent regulatory regions of the HIV genome have been shown to 
inhibit the virus at different stages of the life cycle. Similarly, DNA-
zymes have been used for catalytic cleavage of hepatitis virus genes, 
thus inhibiting further virus proliferation. DNAzyme drugs have also 
been designed to combat antibiotic-resistant bacterial strains., and 
DNAzymes have been designed for specific cleavage of β-lactamase 
and penicillin-binding protein mRNAs in antibiotic-resistant S. aureus 
[100]. Some cardiovascular diseases [101] have also been treated with 
DNAzymes that aim to downregulate the expression of pathologically 
active genes. Specific downregulation of the expression of Egr-1 (tran-
scription factor) can lead to decreased apoptosis and neointima (scar 
tissue) formation in coronary blood vessels. This in turn can contrib-
ute to increased cardiac output, neo- vascularization, and cardiomyo-
cyte regeneration. 
Although DNAzymes have numerous benefits, some limitations 
need to be addressed before DNAzymes can be fully exploited as 
therapeutic agents. The reduced reactivity of DNAzymes adversely 
affects the chemical functionality of the catalytic molecule [102]. The 
vulnerability of the catalytic sequence to nucleases also significantly 
affects the performance of DNAzyme molecules [103]. Therefore, fur-
ther research will be necessary for the development of DNAzyme-
based therapeutic technologies. 
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DNAzyme-Based Nanodevices 
Nanodevices integrate physics, chemistry, mathematics, and biology 
for the nanofabrication of desired assemblies. In the life sciences, DNA 
and proteins are among the most promising materials for the con-
struction of bionanodevices. In particular, nucleotides have only two 
principal types of pairing, A–T or C–G, and this is comparable to the 
binary arithmetic of computers. Hence, information in the form of 
base pairs and self-assembling properties allow DNA to be exploited 
for building nanomachines. 
DNA as a digital coding system opened a new discipline related 
to nanobioelectronics. An important aspect of nanoelectronics re-
search is the generation of novel materials for implementation in de-
vice fabrication [104]. DNAzymes have shown significant potential 
for the design and implementation of bionanodevices for biologi-
cal applications. One specific clinical application of such a DNAzyme-
based digital circuit is as an autonomous self-monitoring treatment 
device. For example, the presence of excessive thrombin can cause 
localized bleeding leading to brain hemorrhage, but the digital re-
lease of therapeutic molecules through a triggered system may re-
duce the risk. Such innovative models will require more research for 
practical applicability. 
Early emphasis was on the development of DNAzyme-based dig-
ital circuits [105]. Different logic gates are integrated to form a dig-
ital system in which DNAzymes are used as both input and output 
devices. In the presence of an appropriate input signal (target), DNA-
zymes cleave the substrate molecule which is then transformed into a 
fluorescence signal. In this way, fluorescence is an accurate output of 
the input signal. This basic computing model has been further modi-
fied for more complex logical operations. Later, Wang and coworkers 
constructed a DNAzyme- and silver microsphere (SMS)-based multi-
digit programmable DNA keypad lock system. In this system, G4-DNA-
zyme–hemin conjugates were immobilized on silver micro-spheres to 
catalyze the chromogenic oxidation of tetramethylbenzidine (TMB) by 
H2O2 [106]. This DNAzyme-based electronic device provides a good 
foundation for nanomedicine, and many immune-based diseases in-
volving deregulation of microRNAs can trigger the switching device 
to release catalytic molecules for their degradation. 
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DNAzymes can be engineered to form a lattice of a finite size, 
also known as DNA origami because of their self-assembly properties 
[107]. These DNA lattices imitate Boolean logic gates and can further 
be implemented to generate different computational programs. The 
components of the circuit are the same (i.e., two inputs and one out-
put). The output of this circuit is a chemiluminescence signal gener-
ated from functionalized AuNPs. 
Another type of DNAzyme-based nanodevice, the ‘light energy-
powered DNA walker system’, was reported by Tan and colleagues 
[108]. The authors demonstrated an independent but regulated DNA-
zyme-based walker system. In this nanorobotic device, a suitable mo-
lecular switch, such as the photosensitive moiety pyrene (aromatic hy-
drocarbon), is incorporated within the DNAzyme. This new approach 
allows precise control of the DNA walker by using light of different 
wavelengths and intensities. The DNA walker system consists of the 
RNA-cleaving 10-23 DNAzyme that moves along a template strand in 
the presence of metal ion cofactors. It has autonomous motion similar 
to that of dynein and kinesin. Research progress in this field allowed 
conjugation of QDs to DNAzymes [105] to construct optical devices 
or quadruplex DNAzymes for chemiluminescence-based nanodevices. 
These nanodevices can be employed in a wide range of applications 
[105], such as the delivery of molecular cargo, biosensing, disintegra-
tion of DNA hydrogels, and signal amplification. Very recently, a DNA-
zyme nanomotor was built that can detect femtomole-level thrombin, 
and this has great potential in clinical diagnosis [109]. 
DNAzymes for Targeted Drug Delivery and Therapy 
DNAzymes can also be utilized as a vehicle for targeted drug delivery. 
The desirable properties of DNAzymes (e.g., low immunogenicity and 
modifiable chemical structure) make them appropriate candidates for 
targeted drug delivery relative to other methods such as liposomes 
and nanocapsulations. DNAzymes can act as stimulus-responsive caps 
to the pores of nanocarriers such as AuNPs and mesoporous SiO2 NPs 
[81,110]. In the presence of an activating factor, DNAzyme-mediated 
cleavage can unlock nanocarrier pores to allow the controlled release 
of drugs. Allosteric DNAzymes also have potential for targeted drug 
delivery. A noncanonical strategy of multifunctional nanoflowers (NFs) 
or nanotrains can also be employed for the delivery of anticancer 
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drugs [111–113]. These noncanonical (non-Watson–Crick base pair-
ing) tunable nanostructures can be self-assembled through rolling-
cycle replication of duplex DNA (template and primer). The character-
istic features of DNA NFs, such as nuclease resistance, exceptionally 
high stability, and the presence of various functional groups, are cru-
cial for versatile biomedical applications. In addition, fluorescent tags 
can also be easily incorporated into the nanomotifs. Hence, NFs can 
be used as dual bioimaging and drug-delivery systems. 
DNAzymes have also been linked to RNA interference (RNAi) sys-
tems as a vehicle for selective delivery of RNAi. The DNAzyme–RNAi 
conjugated system has broad clinical applications in gene regulation 
and drug delivery [114]. Recently, many new concepts of theranos-
tics have evolved, and this new paradigm has been extended to DNA-
zymes because they have shown exponential growth in the field of 
therapeutics [115]. Their functional diversity and catalytic design us-
ing combinatorial selection make DNAzymes particularly interesting 
for theranostic applications. In addition, DNAzymes are easy to label 
and can be employed for real-time detection of analytes. Thus, DNA-
zymes hold great promise in a therapeutic paradigm combining im-
aging and therapy. DNAzyme theranostics remains a relatively new 
concept, but there are diverse potential applications of DNAzymes in 
this new field. 
Concluding Remarks and Future Perspectives 
Since their invention, DNAzymes have displayed exponential growth 
as potent catalysts. This is mainly due to their inherent characteris-
tics, such as high selectivity and specificity, as discussed earlier, and 
because they provide a potential alternative to more traditional bio-
catalysts such as proteins and RNA. One of the main challenges as-
sociated with the application of DNAzymes as in vivo therapeutics is 
that most DNAzymes require high concentrations of divalent metal 
ions for maximal catalytic activity, and these concentrations are mod-
erately higher than the anticipated concentrations in vivo. New DNA-
zymes requiring low in vitro metal ion concentrations [115] are likely 
to function more effectively under in vivo conditions. 
Another limitation of DNAzyme therapeutics relates to their se-
lective delivery into target cells because their large size and charged 
backbone limits cellular uptake. The in vivo performance of therapeutic 
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DNAzymes is directly related to their intracellular stability. Different 
sets of modifications such as circularization, phosphoramidates, locked 
nucleic acid (LNA), 3′–3′ linkages, and modified bases have been re-
ported to increase in vivo stability [116]. 
Further research is needed, particularly in theranostics, and the true 
potential of catalytic DNAzymes has not yet been fully developed be-
cause only a small proportion of sequences have been explored. Sig-
nificant progress in the DNAzyme field depends on the exploration of 
highly specific targets such as miRNA and chronic disease biomark-
ers that have practical diagnostic applications. DNAzyme-based sen-
sitive detection of miRNA may give rise to personalized medicine for 
cancer patients. Likewise, future directions of DNAzyme research in-
clude the use of simulation software for combinatorial library design 
and in vitro selection. This will save time because such computational 
techniques should efficiently provide an estimate of the constructs 
that meet the binding affinity required for such goals. 
Another emerging field related to DNA computation is the forma-
tion of DNAzyme-based programmed nanodevices. DNAzyme-based 
digital circuits may provide a platform for the development of more 
sophisticated nanodevices for medicinal and other biological appli-
cations. Major goals of future research in the context of therapeutics 
are in vivo stability, point-of-care devices, site-directed delivery, and 
monitoring devices. 
Outstanding Questions 
• Recent advances in SELEX have accelerated the automated gener-
ation of DNAzyme molecules, but what further improvements will 
be necessary? 
• What are the specific characteristics of DNAzymes that allow them 
to be used in theranostic applications? 
• What are the roles of RNA cleavage and G-quadruplexes in DNA-
zyme-based sensors? 
• Why have the vast majority of the in vivo drug trials utilized the 10-
23 DNAzyme?
• What are the major factors that affect the in vivo performance of 
DNAzymes? 
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